Guardion Health Sciences Statistics
Share Statistics
Guardion Health Sciences has 1.35M shares outstanding. The number of shares has increased by 5.12% in one year.
| Shares Outstanding | 1.35M |
| Shares Change (YoY) | n/a |
| Shares Change (QoQ) | 5.12% |
| Owned by Institutions (%) | n/a |
| Shares Floating | 1.16M |
| Failed to Deliver (FTD) Shares | 1 |
| FTD / Avg. Volume | 0.03% |
Short Selling Information
The latest short interest is 22.26K, so 1.65% of the outstanding shares have been sold short.
| Short Interest | 22.26K |
| Short % of Shares Out | 1.65% |
| Short % of Float | 1.92% |
| Short Ratio (days to cover) | 0.18 |
Valuation Ratios
The PE ratio is 42.94 and the forward PE ratio is -3.16.
| PE Ratio | 42.94 |
| Forward PE | -3.16 |
| PS Ratio | 0.55 |
| Forward PS | null |
| PB Ratio | 0.83 |
| P/FCF Ratio | -1.55 |
| PEG Ratio | n/a |
Enterprise Valuation
Guardion Health Sciences Inc. has an Enterprise Value (EV) of 426.67K.
| EV / Earnings | 2.7 |
| EV / Sales | 0.03 |
| EV / EBITDA | -0.11 |
| EV / EBIT | -0.1 |
| EV / FCF | -0.1 |
Financial Position
The company has a current ratio of 9.01, with a Debt / Equity ratio of 0.
| Current Ratio | 9.01 |
| Quick Ratio | 6.98 |
| Debt / Equity | 0 |
| Total Debt / Capitalization | 0 |
| Cash Flow / Debt | 0 |
| Interest Coverage | 0 |
Financial Efficiency
Return on equity (ROE) is 0.02% and return on capital (ROIC) is -53.23%.
| Return on Equity (ROE) | 0.02% |
| Return on Assets (ROA) | 0.01% |
| Return on Capital (ROIC) | -53.23% |
| Revenue Per Employee | 1.36M |
| Profits Per Employee | 17.56K |
| Employee Count | 9 |
| Asset Turnover | 1.03 |
| Inventory Turnover | 2.56 |
Taxes
| Income Tax | 0 |
| Effective Tax Rate | 0 |
Stock Price Statistics
The stock price has increased by -37.72% in the last 52 weeks. The beta is 0.71, so Guardion Health Sciences 's price volatility has been higher than the market average.
| Beta | 0.71 |
| 52-Week Price Change | -37.72% |
| 50-Day Moving Average | 3.22 |
| 200-Day Moving Average | 7.36 |
| Relative Strength Index (RSI) | 25.77 |
| Average Volume (20 Days) | 3.40K |
Income Statement
In the last 12 months, Guardion Health Sciences had revenue of 12.25M and earned 158.03K in profits. Earnings per share was 0.12.
| Revenue | 12.25M |
| Gross Profit | 5.39M |
| Operating Income | -4.34M |
| Net Income | 158.03K |
| EBITDA | -3.92M |
| EBIT | -4.34M |
| Earnings Per Share (EPS) | 0.12 |
Balance Sheet
The company has 6.36M in cash and 0 in debt, giving a net cash position of 6.36M.
| Cash & Cash Equivalents | 6.36M |
| Total Debt | 0 |
| Net Cash | 6.36M |
| Retained Earnings | -93.57M |
| Total Assets | 15.30M |
| Working Capital | 14.37M |
Cash Flow
In the last 12 months, operating cash flow was -4.37M and capital expenditures -3.79K, giving a free cash flow of -4.37M.
| Operating Cash Flow | -4.37M |
| Capital Expenditures | -3.79K |
| Free Cash Flow | -4.37M |
| FCF Per Share | -3.44 |
Margins
Gross margin is 44.04%, with operating and profit margins of -35.4% and 1.29%.
| Gross Margin | 44.04% |
| Operating Margin | -35.4% |
| Pretax Margin | 1.29% |
| Profit Margin | 1.29% |
| EBITDA Margin | -32.02% |
| EBIT Margin | -35.4% |
| FCF Margin | -35.71% |
Dividends & Yields
GHSI does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Payout Ratio | n/a |
| Earnings Yield | 3.73% |
| FCF Yield | -100.62% |
Analyst Forecast
Currently there are no analyst rating for GHSI.
| Price Target | n/a |
| Price Target Difference | n/a |
| Analyst Consensus | n/a |
| Analyst Count | n/a |
Stock Splits
The last stock split was on Jan 9, 2023. It was a forward split with a ratio of 50:1.
| Last Split Date | Jan 9, 2023 |
| Split Type | forward |
| Split Ratio | 50:1 |
Scores
| Altman Z-Score | -5.54 |
| Piotroski F-Score | 5 |